Drug intelligence / Profile preview

dihydrocapsiate

Development stage
Preclinical
Lead developer
Ajinomoto
Modality
Small Molecules, Peptides
Administration
Oral
01

Overview

Dihydrocapsiate is a naturally occurring capsinoid compound found in the non-pungent chili pepper strain CH-19 Sweet. Structurally related to capsaicin, it elicits similar thermogenic effects—such as increased energy expenditure and fat oxidation—but without the pungency or gastrointestinal side effects associated with capsaicin. Dihydrocapsiate acts as an agonist of the Transient receptor potential cation channel subfamily V member 1 (TRPV1), promoting postprandial thermogenesis and fat oxidation. It has been investigated for its potential use in metabolic diseases, including obesity and weight management, but is not currently approved as a pharmaceutical drug. The compound is synthesized enzymatically from vanillyl alcohol and 8-methylnonanoic acid[1][2][3][4][6].

Other names
(4-hydroxy-3-methoxyphenyl)methyl 8-methylnonanoate
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on dihydrocapsiate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dihydrocapsiate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call